Atmos Ventures

Atmos Ventures is a venture capital firm founded in 2018 and headquartered in Warsaw, Poland, that invests in early‑stage seed and Series A companies across Europe and North America. The firm focuses on deep technologies such as artificial intelligence, machine learning, quantum computing, custom AI hardware, alternative energy, cloud infrastructure, the Internet of Things, robotics, automation, Web 3.0, and space technology. Atmos Ventures targets companies with the potential to become global players and supports them with expertise from a management team that has experience in Fortune 500 enterprises and investment firms. Its approach is to deliver technology solutions that integrate smoothly into enterprise workflows, facilitating digital transformation without disruption.

Sami Moughrabie

Managing Partner

10 past transactions

Edrone

Venture Round in 2024
Edrone is a CRM platform specializing in autonomous e-commerce marketing automation. It collects, processes, and triggers customer data to understand behavior and engage customers, helping businesses automate marketing activities and boost sales.

Solvemed Limited

Seed Round in 2023
Solvemed Limited stands at the forefront of innovation in neurological care, leveraging advanced AI technology to pioneer precision diagnostics and personalized treatment recommendations. Our cutting-edge solutions empower healthcare professionals with unprecedented insights, enabling early detection and monitoring of neurological disorders such as Parkinson's disease. With a steadfast commitment to improving patient outcomes, we seamlessly integrate our AI-driven platform to revolutionize the landscape of neurology diagnostics and drug discovery. Backed by a dedicated team of experts and powered by state-of-the-art technology, Solvemed Limited remains steadfast in its mission to redefine the standards of neurological care worldwide.

Solvemed Group

Seed Round in 2022
Solvemed Group leverages proprietary machine learning technology to develop digital biomarkers for accurate, early diagnostics and monitoring of neurological conditions, initially focusing on Parkinson's disease. Collaborating with leading research institutions, the company aims to improve patient care and revolutionize drug discovery.

Edrone

Series A in 2022
Edrone is a CRM platform specializing in autonomous e-commerce marketing automation. It collects, processes, and triggers customer data to understand behavior and engage customers, helping businesses automate marketing activities and boost sales.

Malcom Finance

Seed Round in 2022
Malcom Finance provides the fastest financing solution in the market to underserved SMEs in logistics. As the leader in inclusive SME finance in CEE, Malcom empowers the potential of small businesses and allows their owners to focus on leading a growing business.

Nethone

Series A in 2021
Nethone offers a Know Your Users (KYU) risk-detection platform that protects the entire user journey from onboarding to post-payment, using AI-powered profiling to understand each end-user and block risky activity without impacting legitimate users. Its Profiler analyzes thousands of attributes to deliver real-time, actionable recommendations and supports end-to-end protection against more than 100 fraud tactics on websites and mobile apps, including account takeovers, bot attacks, promo abuse, friendly fraud, and card-not-present fraud. The modular platform aims to lower rejection rates and reduce manual review costs while preserving the user experience. Founded in 2016 within Daftcode, Nethone has global ecommerce, digital goods, and financial clients and has been part of Mangopay Group since 2022. It has been recognized as a fast-growing fintech company by The Financial Times and Statista.

Molecule.one

Seed Round in 2021
Molecule.one is a biotechnology company that specializes in artificial intelligence-driven software for chemical synthesis. Its m1 platform enhances the preclinical pipeline by maximizing efficiency in chemistry-related processes. The company’s software predicts the likelihood of synthesizing novel small molecules and automates significant portions of the manual work involved in synthesis design. By leveraging vast datasets that exceed human processing capabilities, Molecule.one enables clients to concentrate on drug candidates that are not only cost-effective to synthesize but also have a higher probability of success in the development process. This integration of AI into chemical synthesis represents a significant advancement in the field, streamlining workflows for bench chemists, data scientists, and computational chemists alike.

Sundose

Series A in 2021
Sundose is a business that specializes in personalized nutrition. It formulates and delivers customized supplement blends tailored to each individual's lifestyle and dietary needs, ensuring they receive dietician-approved nutrients for optimal health and wellbeing.

ORCA Computing

Pre Seed Round in 2020
ORCA Computing develops a photonic quantum computer designed to be scalable and flexible. Founded in 2019 and based in Oxford, United Kingdom, the company focuses on a photonic processor that uses quantum memories to store, synchronize, and buffer quantum operations, improving performance. Its modular, optical fiber–based architecture relies on telecoms photonics and off‑the‑shelf fiber and optical components to create a rack‑mounted platform. By exploiting photonic degrees of freedom, ORCA Computing aims to unlock new applications and accelerate innovation across industries.

Oxford Ionics

Seed Round in 2020
Oxford Ionics specializes in advanced quantum computing systems, focusing on trapped-ion technology. This enables scalable, efficient quantum chips produced via standard semiconductor methods, facilitating advancements in quantum computing and enhancing computational capabilities for complex problems.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.